Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

نویسندگان

  • Phillip J Whiley
  • Miguel de la Hoya
  • Mads Thomassen
  • Alexandra Becker
  • Rita Brandão
  • Inge Sokilde Pedersen
  • Marco Montagna
  • Mireia Menéndez
  • Francisco Quiles
  • Sara Gutiérrez-Enríquez
  • Kim De Leeneer
  • Anna Tenés
  • Gemma Montalban
  • Demis Tserpelis
  • Toshio Yoshimatsu
  • Carole Tirapo
  • Michela Raponi
  • Trinidad Caldes
  • Ana Blanco
  • Marta Santamariña
  • Lucia Guidugli
  • Gorka Ruiz de Garibay
  • Ming Wong
  • Mariella Tancredi
  • Laura Fachal
  • Yuan Chun Ding
  • Torben Kruse
  • Vanessa Lattimore
  • Ava Kwong
  • Tsun Leung Chan
  • Mara Colombo
  • Giovanni De Vecchi
  • Maria Caligo
  • Diana Baralle
  • Conxi Lázaro
  • Fergus Couch
  • Paolo Radice
  • Melissa C Southey
  • Susan Neuhausen
  • Claude Houdayer
  • Jim Fackenthal
  • Thomas Van Overeem Hansen
  • Ana Vega
  • Orland Diez
  • Rien Blok
  • Kathleen Claes
  • Barbara Wappenschmidt
  • Logan Walker
  • Amanda B Spurdle
  • Melissa A Brown
چکیده

BACKGROUND Accurate evaluation of unclassified sequence variants in cancer predisposition genes is essential for clinical management and depends on a multifactorial analysis of clinical, genetic, pathologic, and bioinformatic variables and assays of transcript length and abundance. The integrity of assay data in turn relies on appropriate assay design, interpretation, and reporting. METHODS We conducted a multicenter investigation to compare mRNA splicing assay protocols used by members of the ENIGMA (Evidence-Based Network for the Interpretation of Germline Mutant Alleles) consortium. We compared similarities and differences in results derived from analysis of a panel of breast cancer 1, early onset (BRCA1) and breast cancer 2, early onset (BRCA2) gene variants known to alter splicing (BRCA1: c.135-1G>T, c.591C>T, c.594-2A>C, c.671-2A>G, and c.5467+5G>C and BRCA2: c.426-12_8delGTTTT, c.7988A>T, c.8632+1G>A, and c.9501+3A>T). Differences in protocols were then assessed to determine which elements were critical in reliable assay design. RESULTS PCR primer design strategies, PCR conditions, and product detection methods, combined with a prior knowledge of expected alternative transcripts, were the key factors for accurate splicing assay results. For example, because of the position of primers and PCR extension times, several isoforms associated with BRCA1, c.594-2A>C and c.671-2A>G, were not detected by many sites. Variation was most evident for the detection of low-abundance transcripts (e.g., BRCA2 c.8632+1G>A Δ19,20 and BRCA1 c.135-1G>T Δ5q and Δ3). Detection of low-abundance transcripts was sometimes addressed by using more analytically sensitive detection methods (e.g., BRCA2 c.426-12_8delGTTTT ins18bp). CONCLUSIONS We provide recommendations for best practice and raise key issues to consider when designing mRNA assays for evaluation of unclassified sequence variants.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

I-5: Semen Analysis - Clinical Laboratories; Is Standardization Applied?

Reduced semen quality is commonly claimed to be one of the main signs of male infertility and thus, analysis of semen is recommended as the cornerstone of a male fertility investigation. However, to control possible sources of physiological and methodological variation, and to generate reliable information on semen quality that can be accurately compared across different laboratories, semen ana...

متن کامل

Restoration of correct splicing in IVSI-110 mutation of β-globin gene with antisense oligonucleotides: implications and applications in functional assay development

Objective(s): The use of antisense oligonucleotides (AOs) to restore normal splicing by blocking the recognition of aberrant splice sites by the spliceosome represents an innovative means of potentially controlling certain inherited disorders affected by aberrant splicing. Selection of the appropriate target site is essential in the success of an AO therapy. In this study, in search for a splic...

متن کامل

Prothrombin time testing practices: adherence to guidelines and standards.

Coagulation laboratory tests are vital to the diagnosis, treatment, and management of bleeding and hypercoagulability disorders. Some laboratories, however, fail to follow voluntary practice guidelines for coagulation testing (1, 2), and inappropriate performance of coagulation tests, such as the prothrombin time (PT) test, may contribute to coagulation and bleeding complications (3, 4). A 2001...

متن کامل

مقایسه حساسیت و ویژگی روشهای تشخیصی توکسوپلاسموز براساس سنجش

    Background & Aim: Toxoplasmosis is a common disease between human and animal with an extensive distribution. It is caused by the parasitical protozoan Toxoplasma gondii. Most clinical laboratories have problems with the diagnosis of toxoplasmosis. The aim of this study is the comparison of sensitivity and specificity of conventional and unconventional methods in the diagnosis of Toxoplasmos...

متن کامل

Comparison of Knowledge and Practice of Private Clinical Laboratories and Educational Centers Staff in Shiraz about AIDS,2011

Abstract Background and objectives: Acquired immune deficiency syndrome(AIDS) is one of the most well-known disease in the world .It is not only A heaththrapeutic problem but also with politic ,social, cultural and economic aspects. Paying attention to high-risk groups such as Lab staff is important. we decided to study and compare the knowledge of public and private Laboratories staff. Materia...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical chemistry

دوره 60 2  شماره 

صفحات  -

تاریخ انتشار 2014